+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dog Vaccines Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Dog Vaccines Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Dog Vaccines Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6082448
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Dog Vaccines Market grew from USD 2.21 billion in 2024 to USD 2.40 billion in 2025. It is expected to continue growing at a CAGR of 8.06%, reaching USD 3.53 billion by 2030.

The global canine vaccine sector has evolved into a pivotal component of preventive veterinary care, driven by heightened awareness of zoonotic threats and a deepening human-animal bond. Advances in molecular biology and veterinary immunology have unlocked new modalities, allowing for broader pathogen coverage and tailored immunization protocols. Concurrently, regulatory agencies have updated guidelines to ensure both safety and efficacy, encouraging innovation while maintaining stringent quality standards. As pet ownership surges, fueled by urbanization and shifting demographic profiles, the demand for comprehensive vaccination strategies that address a spectrum of diseases-from core pathogens such as distemper and parvovirus to emergent threats like leptospirosis-has intensified. This introductory overview frames the dynamic forces reshaping the dog vaccines market, setting the stage for an analysis of transformative shifts, tariff impacts, segmentation insights, regional dynamics, and strategic imperatives for stakeholders looking to navigate this rapidly evolving landscape.

Transformative Shifts in the Dog Vaccines Landscape

Over the past decade, the dog vaccines arena has experienced transformative shifts driven by technological breakthroughs and evolving consumer expectations. Precision medicine principles have migrated from human healthcare into veterinary applications, enabling DNA and viral vector platforms to deliver targeted immune responses. Digital innovations-ranging from tele-veterinary consultations to blockchain-based cold-chain tracking-have streamlined distribution, enhanced compliance, and reduced wastage. Humanization trends, underpinned by pet owners’ willingness to invest in premium healthcare, have prompted manufacturers to expand non-core vaccine portfolios, addressing conditions such as Lyme disease and kennel cough.

Concurrently, regulatory harmonization across major markets, notably between North America and the European Union, has accelerated vaccine approvals while enforcing rigorous post-market surveillance protocols. Public-private collaborations are now fostering accelerated research into emergent vaccine candidates, particularly those combating canine influenza and leptospirosis. Meanwhile, environmental and animal welfare considerations are driving the development of needle-free delivery systems, such as intranasal and oral formulations, minimizing stress for both animals and caregivers. Together, these shifts underscore a market in flux-one where agility, technological integration, and consumer-centric innovation form the bedrock of competitive advantage.

Cumulative Impact of US Tariffs Effective in 2025

The imposition of new United States tariffs in 2025 has introduced a layer of complexity to the global supply chain for canine vaccines. Tariffs on imported biological materials and active pharmaceutical ingredients have elevated production costs, compelling manufacturers to reassess sourcing strategies and pass incremental expenses to end users. These measures have also catalyzed nearshoring initiatives, with several vaccine producers expanding local manufacturing footprint to mitigate import duties and secure uninterrupted supply.

Moreover, elevated trade barriers have intensified price sensitivity among veterinary practices and pet care centers, accelerating the adoption of generic or biosimilar vaccines. In response, leading developers are optimizing manufacturing efficiencies by integrating continuous bioprocessing and single-use technologies. At the same time, strategic alliances between domestic CMOs and multinational corporations are emerging to leverage tariff exemptions for technology transfers and co-production agreements. As this tariff regime matures, stakeholders who proactively adapt their supply chains and invest in localized production will be better positioned to sustain margins and maintain market share.

Key Segmentation Insights

A nuanced understanding of market segments provides a roadmap for targeted investment and resource allocation. Based on vaccine type, core vaccines continue to dominate but rapid growth in DNA vaccines and viral vector platforms is reshaping R&D prioritization. Considering vaccine form, injectable products still account for the majority of administrations, yet nasal vaccines are gaining traction for kennel cough prevention, and oral formulations are recognized for their stress-free delivery. In terms of age group, differential immunization protocols for adult dogs, puppies, and senior dogs underscore the necessity for tailored dosage regimens and safety profiles. When evaluating end-user dynamics, animal hospitals remain primary demand drivers, while home care vaccination kits reflect a growing DIY consumer segment; pet care centers and veterinary clinics also contribute distinct volume streams.

Technology-wise, traditional inactivated vaccines coexist with live attenuated and recombinant technologies, each offering unique stability and efficacy profiles. Application-based segmentation highlights the strategic importance of canine distemper, parvovirus, and rabies prevention, alongside specialized products for Lyme disease and kennel cough. Distribution channels vary from online stores capturing tech-savvy consumers to retail pharmacies-both chain and independent-leveraging brand recognition and veterinary distributors optimizing professional networks. Breed size considerations differentiate protocols for large, medium, and small dogs, influencing dosage packaging and pricing strategies. Vaccination frequency segmentation, spanning annual, single-dose, and triennial schedules, informs lifecycle marketing and compliance initiatives. Finally, emergent vaccines targeting Bordetella bronchiseptica, canine influenza, and leptospirosis represent high-growth niches as veterinarians and pet owners seek expanded protective coverage.

Key Regional Insights

Regional dynamics reveal divergent growth trajectories and strategic priorities. In the Americas, robust pet ownership rates and established veterinary networks underpin steady demand for both core and advanced vaccines; the United States remains a technology leader, while Brazil’s expanding middle class fuels uptake of premium formulations. Within Europe, Middle East & Africa, regulatory convergence across the EU and proactive animal health policies in the Gulf Cooperation Council have accelerated approvals, whereas certain African markets are emerging as critical battlegrounds for cost-effective delivery solutions. Growth in Asia-Pacific is particularly striking, driven by rising disposable incomes, urban pet companionship in China and India, and government-led disease control initiatives in Australia and Japan. Cross-regional partnerships, especially between Asia-Pacific manufacturers and European technology licensors, are redefining the competitive landscape and establishing new hubs for vaccine innovation.

Key Company Insights

Competitive intensity in the dog vaccines market is shaped by a mix of global powerhouses and specialized innovators. Aratana Therapeutics, Inc. is advancing immunotherapeutic adjuvants while Bayer Animal Health GmbH leverages its extensive R&D infrastructure to refine recombinant platforms. Biogenesis Bago’s regional manufacturing clout in Latin America contrasts with Boehringer Ingelheim Animal Health’s diversified pipeline spanning live attenuated and DNA vaccines. Ceva Santé Animale focuses on intranasal solutions, whereas Chanelle Pharma Group excels in cost-effective inactivated vaccines for emerging markets. Dechra Pharmaceuticals PLC and Elanco Animal Health Incorporated prioritize metabolic and parasitic comorbidities in multi-component formulations. Heska Corporation’s diagnostic integration enhances vaccine compliance analytics, while Hipra’s leadership in recombinant technologies reshapes immunization strategies.

Industry stalwarts such as IDEXX Laboratories, Inc. are integrating diagnostics and vaccine protocols to bolster preventative care, paralleled by Intas Pharmaceuticals Ltd.’s aggressive biosimilar expansion. Kyoritsu Seiyaku Corporation’s domestic stronghold in Japan complements Merck & Co., Inc.’s global commercialization network. Merial Ltd.’s legacy in core pathogen prevention underpins Neogen Corporation’s biosecurity-focused offerings. Phibro Animal Health Corporation and Vetoquinol S.A. emphasize specialty vaccines for high-risk conditions, while Virbac S.A.’s robust distribution channels strengthen Zoetis Inc.’s market leadership across all major geographies. Collectively, these players drive innovation, shape pricing dynamics, and influence regulatory agendas worldwide.

Actionable Recommendations for Industry Leaders

To thrive amid evolving market conditions, industry leaders should accelerate integration of next-generation vaccine platforms by prioritizing recombinant and viral vector technologies that offer rapid scalability and cross-protection. Strengthen supply chain resilience through diversified sourcing and strategic partnerships with local CMOs, ensuring tariff exposures are mitigated and cold-chain integrity is preserved. Enhance customer engagement by deploying digital health ecosystems-mobile compliance apps, telemedicine links, and data-driven diagnostic tools-to drive adherence and foster long-term loyalty.

Adopt tiered pricing models aligned with regional purchasing power, balancing affordability in emerging markets with premium offerings in high-income regions. Cultivate collaborative R&D consortia that pool resources across academia, biotech startups, and regulatory bodies to accelerate pipeline progression for emergent vaccines. Invest in needle-free delivery innovations to improve safety, reduce animal stress, and capture market share in the rising home care segment. Finally, establish robust pharmacovigilance frameworks that leverage real-world evidence to refine immunization protocols, elevate trust with veterinarians and pet owners, and inform iterative product enhancements.

Conclusion and Strategic Imperatives

The canine vaccine market stands at the intersection of technological innovation, shifting regulatory landscapes, and evolving pet owner expectations. As the sector navigates tariff fluctuations and intensifying competition, success will hinge on the ability to harness next-generation platforms, fortify supply chains, and deliver differentiated value through digital engagement. Segmentation-driven insights underscore the importance of tailored strategies across vaccine types, end-user channels, and regional markets. Meanwhile, proactive collaboration with key stakeholders-ranging from contract manufacturers to diagnostic partners-will accelerate time to market and amplify impact. Ultimately, organizations that meld scientific rigor with agile commercialization models will secure leadership in an increasingly complex and competitive environment.

Market Segmentation & Coverage

This research report categorizes the Dog Vaccines Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Core Vaccines
  • DNA Vaccines
  • Non-Core Vaccines
  • Viral Vector Vaccines
  • Injectable Vaccines
  • Nasal Vaccines
  • Oral Vaccines
  • Adult Dogs
  • Puppies
  • Senior Dogs
  • Animal Hospitals
  • Home Care
  • Pet Care Centers
  • Veterinary Clinics
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines
  • Canine Distemper Prevention
  • Kennel Cough Prevention
  • Lyme Disease Prevention
  • Parvovirus Prevention
  • Rabies Prevention
  • Online Stores
  • Retail Pharmacies
    • Chain Pharmacies
    • Independent Pharmacies
  • Veterinary Distributors
  • Large Breeds
  • Medium Breeds
  • Small Breeds
  • Annual Vaccinations
  • Single-Dose Vaccinations
  • Triennial Vaccinations
  • Bordetella Bronchiseptica Vaccines
  • Canine Influenza Vaccines
  • Leptospirosis Vaccines

This research report categorizes the Dog Vaccines Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Dog Vaccines Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Aratana Therapeutics, Inc.
  • Bayer Animal Health GmbH
  • Biogenesis Bago
  • Boehringer Ingelheim Animal Health
  • Ceva Santé Animale
  • Chanelle Pharma Group
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • Hipra
  • IDEXX Laboratories, Inc.
  • Intas Pharmaceuticals Ltd.
  • Kyoritsu Seiyaku Corporation
  • Merck & Co., Inc.
  • Merial Ltd.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dog Vaccines Market, by Vaccine Type
8.1. Introduction
8.2. Core Vaccines
8.3. DNA Vaccines
8.4. Non-Core Vaccines
8.5. Viral Vector Vaccines
9. Dog Vaccines Market, by Vaccine Form
9.1. Introduction
9.2. Injectable Vaccines
9.3. Nasal Vaccines
9.4. Oral Vaccines
10. Dog Vaccines Market, by Age Group
10.1. Introduction
10.2. Adult Dogs
10.3. Puppies
10.4. Senior Dogs
11. Dog Vaccines Market, by End-User
11.1. Introduction
11.2. Animal Hospitals
11.3. Home Care
11.4. Pet Care Centers
11.5. Veterinary Clinics
12. Dog Vaccines Market, by Technology
12.1. Introduction
12.2. Inactivated Vaccines
12.3. Live Attenuated Vaccines
12.4. Recombinant Vaccines
13. Dog Vaccines Market, by Application
13.1. Introduction
13.2. Canine Distemper Prevention
13.3. Kennel Cough Prevention
13.4. Lyme Disease Prevention
13.5. Parvovirus Prevention
13.6. Rabies Prevention
14. Dog Vaccines Market, by Distribution Channel
14.1. Introduction
14.2. Online Stores
14.3. Retail Pharmacies
14.3.1. Chain Pharmacies
14.3.2. Independent Pharmacies
14.4. Veterinary Distributors
15. Dog Vaccines Market, by Breed Size
15.1. Introduction
15.2. Large Breeds
15.3. Medium Breeds
15.4. Small Breeds
16. Dog Vaccines Market, by Vaccination Frequency
16.1. Introduction
16.2. Annual Vaccinations
16.3. Single-Dose Vaccinations
16.4. Triennial Vaccinations
17. Dog Vaccines Market, by Emergent Vaccines
17.1. Introduction
17.2. Bordetella Bronchiseptica Vaccines
17.3. Canine Influenza Vaccines
17.4. Leptospirosis Vaccines
18. Americas Dog Vaccines Market
18.1. Introduction
18.2. Argentina
18.3. Brazil
18.4. Canada
18.5. Mexico
18.6. United States
19. Asia-Pacific Dog Vaccines Market
19.1. Introduction
19.2. Australia
19.3. China
19.4. India
19.5. Indonesia
19.6. Japan
19.7. Malaysia
19.8. Philippines
19.9. Singapore
19.10. South Korea
19.11. Taiwan
19.12. Thailand
19.13. Vietnam
20. Europe, Middle East & Africa Dog Vaccines Market
20.1. Introduction
20.2. Denmark
20.3. Egypt
20.4. Finland
20.5. France
20.6. Germany
20.7. Israel
20.8. Italy
20.9. Netherlands
20.10. Nigeria
20.11. Norway
20.12. Poland
20.13. Qatar
20.14. Russia
20.15. Saudi Arabia
20.16. South Africa
20.17. Spain
20.18. Sweden
20.19. Switzerland
20.20. Turkey
20.21. United Arab Emirates
20.22. United Kingdom
21. Competitive Landscape
21.1. Market Share Analysis, 2024
21.2. FPNV Positioning Matrix, 2024
21.3. Competitive Analysis
21.3.1. Aratana Therapeutics, Inc.
21.3.2. Bayer Animal Health GmbH
21.3.3. Biogenesis Bago
21.3.4. Boehringer Ingelheim Animal Health
21.3.5. Ceva Santé Animale
21.3.6. Chanelle Pharma Group
21.3.7. Dechra Pharmaceuticals PLC
21.3.8. Elanco Animal Health Incorporated
21.3.9. Heska Corporation
21.3.10. Hipra
21.3.11. IDEXX Laboratories, Inc.
21.3.12. Intas Pharmaceuticals Ltd.
21.3.13. Kyoritsu Seiyaku Corporation
21.3.14. Merck & Co., Inc.
21.3.15. Merial Ltd.
21.3.16. Neogen Corporation
21.3.17. Phibro Animal Health Corporation
21.3.18. Vetoquinol S.A.
21.3.19. Virbac S.A.
21.3.20. Zoetis Inc.
22. ResearchAI
23. ResearchStatistics
24. ResearchContacts
25. ResearchArticles
26. Appendix
List of Figures
FIGURE 1. DOG VACCINES MARKET MULTI-CURRENCY
FIGURE 2. DOG VACCINES MARKET MULTI-LANGUAGE
FIGURE 3. DOG VACCINES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DOG VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DOG VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DOG VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DOG VACCINES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DOG VACCINES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL DOG VACCINES MARKET SIZE, BY BREED SIZE, 2024 VS 2030 (%)
FIGURE 22. GLOBAL DOG VACCINES MARKET SIZE, BY BREED SIZE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2024 VS 2030 (%)
FIGURE 24. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2024 VS 2030 (%)
FIGURE 26. GLOBAL DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 30. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. DOG VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 36. DOG VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DOG VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DOG VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DOG VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DOG VACCINES MARKET SIZE, BY CORE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DOG VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DOG VACCINES MARKET SIZE, BY VIRAL VECTOR VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DOG VACCINES MARKET SIZE, BY INJECTABLE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DOG VACCINES MARKET SIZE, BY NASAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DOG VACCINES MARKET SIZE, BY ORAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DOG VACCINES MARKET SIZE, BY ADULT DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DOG VACCINES MARKET SIZE, BY PUPPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DOG VACCINES MARKET SIZE, BY SENIOR DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DOG VACCINES MARKET SIZE, BY ANIMAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DOG VACCINES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DOG VACCINES MARKET SIZE, BY PET CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DOG VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DOG VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DOG VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DOG VACCINES MARKET SIZE, BY CANINE DISTEMPER PREVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DOG VACCINES MARKET SIZE, BY KENNEL COUGH PREVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DOG VACCINES MARKET SIZE, BY LYME DISEASE PREVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DOG VACCINES MARKET SIZE, BY PARVOVIRUS PREVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DOG VACCINES MARKET SIZE, BY RABIES PREVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DOG VACCINES MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DOG VACCINES MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DOG VACCINES MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DOG VACCINES MARKET SIZE, BY LARGE BREEDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DOG VACCINES MARKET SIZE, BY MEDIUM BREEDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DOG VACCINES MARKET SIZE, BY SMALL BREEDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DOG VACCINES MARKET SIZE, BY ANNUAL VACCINATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DOG VACCINES MARKET SIZE, BY SINGLE-DOSE VACCINATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DOG VACCINES MARKET SIZE, BY TRIENNIAL VACCINATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DOG VACCINES MARKET SIZE, BY BORDETELLA BRONCHISEPTICA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DOG VACCINES MARKET SIZE, BY CANINE INFLUENZA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DOG VACCINES MARKET SIZE, BY LEPTOSPIROSIS VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 87. CANADA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 88. CANADA DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 89. CANADA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 90. CANADA DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. CANADA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. CANADA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. CANADA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. CANADA DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 95. CANADA DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 96. CANADA DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 97. CANADA DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 98. MEXICO DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 100. MEXICO DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 101. MEXICO DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. MEXICO DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. MEXICO DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. MEXICO DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. MEXICO DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 106. MEXICO DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 108. MEXICO DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. AUSTRALIA DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 141. AUSTRALIA DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 144. CHINA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 145. CHINA DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 146. CHINA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. CHINA DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. CHINA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. CHINA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. CHINA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. CHINA DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 152. CHINA DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 153. CHINA DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 154. CHINA DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 155. INDIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 156. INDIA DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 157. INDIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 158. INDIA DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. INDIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. INDIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. INDIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. INDIA DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 163. INDIA DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 164. INDIA DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 165. INDIA DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. INDONESIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. INDONESIA DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 174. INDONESIA DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 175. INDONESIA DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 176. INDONESIA DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 177. JAPAN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 178. JAPAN DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 179. JAPAN DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 180. JAPAN DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. JAPAN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. JAPAN DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. JAPAN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. JAPAN DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 185. JAPAN DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 186. JAPAN DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 187. JAPAN DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 188. MALAYSIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. MALAYSIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. MALAYSIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. MALAYSIA DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 196. MALAYSIA DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 197. MALAYSIA DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 198. MALAYSIA DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 199. PHILIPPINES DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 202. PHILIPPINES DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. PHILIPPINES DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. PHILIPPINES DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. PHILIPPINES DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 207. PHILIPPINES DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 208. PHILIPPINES DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 210. SINGAPORE DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 213. SINGAPORE DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. SINGAPORE DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. SINGAPORE DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. SINGAPORE DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. SINGAPORE DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 218. SINGAPORE DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 221. SOUTH KOREA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. SOUTH KOREA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. SOUTH KOREA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. SOUTH KOREA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. SOUTH KOREA DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 229. SOUTH KOREA DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. TAIWAN DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. TAIWAN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. TAIWAN DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 240. TAIWAN DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 241. TAIWAN DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 242. TAIWAN DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 243. THAILAND DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 244. THAILAND DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 245. THAILAND DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 246. THAILAND DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. THAILAND DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. THAILAND DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. THAILAND DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. THAILAND DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 251. THAILAND DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 252. THAILAND DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 253. THAILAND DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 254. VIETNAM DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 255. VIETNAM DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 256. VIETNAM DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 257. VIETNAM DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. VIETNAM DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. VIETNAM DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. VIETNAM DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. VIETNAM DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 262. VIETNAM DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 263. VIETNAM DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 264. VIETNAM DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 277. DENMARK DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 278. DENMARK DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 279. DENMARK DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 280. DENMARK DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. DENMARK DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. DENMARK DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. DENMARK DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. DENMARK DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 285. DENMARK DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 286. DENMARK DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 287. DENMARK DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 288. EGYPT DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 289. EGYPT DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 290. EGYPT DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 291. EGYPT DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 292. EGYPT DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. EGYPT DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. EGYPT DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. EGYPT DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 296. EGYPT DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 297. EGYPT DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 298. EGYPT DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 299. FINLAND DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 300. FINLAND DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 301. FINLAND DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 302. FINLAND DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 303. FINLAND DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 304. FINLAND DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. FINLAND DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. FINLAND DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 307. FINLAND DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 308. FINLAND DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 309. FINLAND DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 310. FRANCE DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 311. FRANCE DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 312. FRANCE DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 313. FRANCE DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 314. FRANCE DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. FRANCE DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. FRANCE DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. FRANCE DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 318. FRANCE DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 319. FRANCE DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 320. FRANCE DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 321. GERMANY DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 322. GERMANY DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 323. GERMANY DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 324. GERMANY DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 325. GERMANY DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 326. GERMANY DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. GERMANY DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. GERMANY DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 329. GERMANY DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 330. GERMANY DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 331. GERMANY DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 332. ISRAEL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 333. ISRAEL DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 334. ISRAEL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 335. ISRAEL DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 336. ISRAEL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 337. ISRAEL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. ISRAEL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 339. ISRAEL DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 340. ISRAEL DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 341. ISRAEL DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 342. ISRAEL DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 343. ITALY DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 344. ITALY DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 345. ITALY DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 346. ITALY DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 347. ITALY DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 348. ITALY DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 349. ITALY DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 350. ITALY DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 351. ITALY DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 352. ITALY DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 353. ITALY DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 354. NETHERLANDS DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 355. NETHERLANDS DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 356. NETHERLANDS DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 357. NETHERLANDS DOG VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 358. NETHERLANDS DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 359. NETHERLANDS DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 360. NETHERLANDS DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 361. NETHERLANDS DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 362. NETHERLANDS DOG VACCINES MARKET SIZE, BY BREED SIZE, 2018-2030 (USD MILLION)
TABLE 363. NETHERLANDS DOG VACCINES MARKET SIZE, BY VACCINATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 364. NETHERLANDS DOG VACCINES MARKET SIZE, BY EMERGENT VACCINES, 2018-2030 (USD MILLION)
TABLE 365. NIGERIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 366. NIGERIA DOG VACCINES MARKET SIZE, BY VACCINE FORM, 2018-2030 (USD MILLION)
TABLE 367. NIGERIA DOG VACCINES MARKET SIZE, BY AGE

Companies Mentioned

  • Aratana Therapeutics, Inc.
  • Bayer Animal Health GmbH
  • Biogenesis Bago
  • Boehringer Ingelheim Animal Health
  • Ceva Santé Animale
  • Chanelle Pharma Group
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • Hipra
  • IDEXX Laboratories, Inc.
  • Intas Pharmaceuticals Ltd.
  • Kyoritsu Seiyaku Corporation
  • Merck & Co., Inc.
  • Merial Ltd.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Dog Vaccines Market by Vaccine Type, Technology, End User, Distribution Channel, Application, Age Group, Dog Size - Global Forecast 2025-2030 - Product Image

Dog Vaccines Market by Vaccine Type, Technology, End User, Distribution Channel, Application, Age Group, Dog Size - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Dog Vaccines Market Size, Share & Trends Analysis Report By Vaccine Type, By Disease Type, By Route Of Administration, By Duration Of Immunity, By Component, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Dog Vaccines Market Size, Share & Trends Analysis Report By Vaccine Type, By Disease Type, By Route Of Administration, By Duration Of Immunity, By Component, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Rabies Veterinary Vaccines Market Size, Share & Trends Analysis Report By Application, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Rabies Veterinary Vaccines Market Size, Share & Trends Analysis Report By Application, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Dog Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Dog Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Dog Vaccine - Global Strategic Business Report - Product Image

Dog Vaccine - Global Strategic Business Report

  • Report
  • 576 Pages
  • Global
From

About the Canine Vaccine Market

The Canine Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and distribution of vaccines for dogs. Vaccines are used to protect dogs from a variety of diseases, including rabies, distemper, parvovirus, and leptospirosis. Vaccines are typically administered by veterinarians, and may be given as a single dose or as a series of doses. Vaccines are also available in a variety of forms, including injectable, oral, and intranasal. In addition to vaccines, the Canine Vaccine market also includes products such as flea and tick control, heartworm prevention, and other health-related products. These products are designed to help keep dogs healthy and reduce the risk of disease. Some of the companies in the Canine Vaccine market include Merck Animal Health, Zoetis, Elanco, Boehringer Ingelheim, and Virbac. These companies produce a variety of vaccines and other products for dogs, and are committed to providing quality products to pet owners. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.